IBIO – Page 2 – Welcome to stockcalc’s blog archive. We’ve launched a new blog! Visit us here.

AnaptysBio (ANAB:NAS) Fundamental Valuation Report

By admin Posted on April 19, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report AnaptysBio(ANAB:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$22.07 (USD) 04/15/2021 Weighted Valuation$29.03 (USD) Overall RatingUndervalued by 31.6% Valuation Models Comparables: $35.39 (USD) Adjusted Book Value: $35.72 …

AnaptysBio (ANAB:NAS) Fundamental Valuation Report Read more »

Albireo Pharma (ALBO:NAS) Fundamental Valuation Report

By admin Posted on April 16, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Albireo Pharma(ALBO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$32.92 (USD) 04/15/2021 Weighted Valuation$31.89 (USD) Overall RatingFairly valued to slightly Overvalued by 3.1% Valuation Models Adjusted …

Albireo Pharma (ALBO:NAS) Fundamental Valuation Report Read more »

Alector (ALEC:NAS) Fundamental Valuation Report

By admin Posted on April 16, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Alector(ALEC:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$18.48 (USD) 04/15/2021 Weighted Valuation$18.21 (USD) Overall RatingFairly valued to slightly Overvalued by 1.5% Valuation Models Comparables: $14.55 (USD) …

Alector (ALEC:NAS) Fundamental Valuation Report Read more »

Aclaris Therapeutics (ACRS:NAS) Fundamental Valuation Report

By admin Posted on April 15, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Aclaris Therapeutics(ACRS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$27.82 (USD) 04/14/2021 Weighted Valuation$9.19 (USD) Overall RatingOvervalued by 67.0% Valuation Models Comparables: $9.19 (USD) Valuation Methods …

Aclaris Therapeutics (ACRS:NAS) Fundamental Valuation Report Read more »

Akebia Therapeutics (AKBA:NAS) Fundamental Valuation Report

By admin Posted on April 15, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Akebia Therapeutics(AKBA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$3.12 (USD) 04/14/2021 Weighted Valuation$3.53 (USD) Overall RatingUndervalued by 13.4% Valuation Models Adjusted Book Value: $3.53 (USD) …

Akebia Therapeutics (AKBA:NAS) Fundamental Valuation Report Read more »

Synthetic Biologics (SYN:ASE) and Centrus Energy (LEU:ASE) Trading at Less than Cash Value

By Brian Donovan Posted on January 16, 2019 Posted in Stocks Trading at Less than Cash Value

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

Synthetic Biologics (SYN:ASE) and Centrus Energy (LEU:ASE) Trading at Less than Cash Value Read more »

Tag: IBIO